MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

NCT03916679 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

BIOLOGICAL: anti-MESO CAR-T cells

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University